Sentences with phrase «third forming a government»

Nick said: «How could our parties overcome the accusations about two parties which came second and third forming a government, and could we actually form a stable government?»

«How could our parties overcome the accusations about two parties which came second and third forming a government, and could we actually form a stable government?

Not exact matches

Another is Montreal - based iNovia Capital, which raised $ 110 million for its third fund in December 2011, $ 10 million of that coming from Alberta Enterprise, an Alberta government - funded corporation formed in 2008 that gives money to VC funds.

Third, the Liberals have proposed major changes to how Parliament would function, including resumption of door - to - door mail delivery, restoration of the long - form census, increased access to all government data, among others.

Governments in most Third World countries, supported by development policies in First and Second World countries, have been concerned about supplying sophisticated forms of energy for industrialization and urban life.

I can not be alone in thinking that it would be more beneficial for the government to be spending their scarce pennies on recovering lost VAT and creating an education programme to make it easier for individuals - and businesses - to fill in their tax forms correctly, when a massive two - thirds (65.9 %) of the lost revenue comes from these areas.

E.g. Yisrael Beiteinu (until October 2012 the third largest party in Knesset, and which has just merged with Likud into what is generally considered the strongest party in Israel, Likud Yisrael Beiteinu)- has had as its electoral planks, and introduced into 15th Knesset - the creation of Constitution (as well as a change to Presidential form of government).

If the Government's economic medicine is perceived to have worked, he knows he may well need to form a coalition with the third party to have any hope of becoming prime minister.

(f) The final option would be if both Labour and the Conservatives were too far from an overall majority to form a government without the Liberal Democrats, and that the Lib Dems (coming either first or second in the popular vote, though still third in number of seats) decide not to allow either to form a functioning government.

Thus, with the acquiescence of Asquith's Liberals, Ramsay MacDonald became the first ever Labour Prime Minister in January 1924, forming the first Labour government, despite Labour only having 191 MPs (less than a third of the House of Commons).

The third Jones government is a Labour — Liberal Democrat coalition government formed after the results of the 2016 general election in Wales.

The Act only permits an early dissolution if Parliament votes for one by a two - thirds supermajority, or if a vote of no confidence is passed by a majority and no new government is subsequently formed within 14 days.

Improving health care delivery is crucial for Puerto Rico, New York officials have said, because two - thirds of the island's population rely on some form of government - run health care.

The speculation was as detailed as it was impossible to confirm: exploratory talks had already been had with Nick Clegg over the possibility of a post-election deal; Clegg had delivered what the plotters wanted to hear: he could work with Labour, but not with Brown; in the event that Labour came third in the poll of votes, but with enough seats to form a coalition government and keep the Tories out, Brown would have to go — and quickly.

Furthermore, the forthcoming general election is far more likely than the last two to end up with the third party being squeezed as the country faces a fundamental choice between Labour and the Conservatives as to who should form the Government.

Third, the government would set up a process to identify and repeal the 30 most hated government rules and forms.

Academics have decried what they say is government meddling in the organization and oversight of both TÜBİTAK and the Turkish Academy of Sciences, which led to one - third of the academy members resigning and forming a new independent Science Academy.

These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, uncertainty regarding potential future deterioration in the market for auction rate securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 form collaborative relationships, uncertainty regarding potential future deterioration in the market for auction rate securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 Form 10 - Q or Current Reports on Form 8 Form 8 - K.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 Form 10 - Q or Current Reports on Form 8 Form 8 - K.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, the outcome of the review of the continued listing of our common stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 Form 10 - Q or Current Reports on Form 8 Form 8 - K.

The third side of the triangle is formed by the government agencies that produce goods, regulations, and services of interest to the producer group (figure 1 - 1).

The negotiations that followed would test flexibility on three fronts: first, how much a newly elected domestic government can deviate from the promises to which a country has already subscribed, second, what leeway is left from the central EU economic priorities as specified by the Eurogroup and the Troika, and third, how much the legal and institutional framework described above can be softened and replaced by some form of «political negotiation».

The Social Justice Package was to form the third part of the Government's response.